CompositionLapatip 250 Tablet 30 is used to manage metastatic breast cancer, particularly HER2-positive breast cancer that has spread to other parts of the body. It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which are specialised anticancer medications.
This medicine is typically prescribed as part of combination therapy with other anticancer agents such as capecitabine, trastuzumab, letrozole, or anastrozole. The combination approach has been shown to achieve better therapeutic outcomes compared to using a single medicine alone, especially for patients whose cancer has continued to progress despite previous treatments.
You should take this medicine exactly as directed by your doctor, on an empty stomach, either one hour before or two hours after eating. It is important to inform your doctor about any pre-existing medical conditions or ongoing medications before starting this treatment. If you notice any side effects while taking this medicine, notify your doctor immediately.
